Ryan Allway November 4th, 2022 News, Top News CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multi-state operator and the No. 1 U.S. wholesaler of branded cannabis, and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”), today announced the signing of definitive agreements to divest certain New York, Illinois,... Read more
Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression
November 4, 2022
Ryan Allway November 4th, 2022 Psychedelics, Top News TORONTO, November 04, 2022–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind Labs” or the “Company“) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological and psychiatric disorders by scientifically harnessing... Read more
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2022 RESULTS AND ANNOUNCES APPOINTMENT OF DR SEUFER-WASSERTHAL AS PRESIDENT AND CEO
November 3, 2022
Ryan Allway November 3rd, 2022 News, Top News CALGARY, AB AND MOUNTAIN VIEW, CA, Nov. 3, 2022 /CNW/ – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, has released its financial and operating results... Read more
Software Effective Solutions’ (OTC: SFWJ) Medcana Acquires Controlling Stake in Eko2o Environmental
November 3, 2022
New Orleans, Louisiana | November 03, 2022 – McapMediaWire — Software Effective Solutions Corporation (OTC: SFWJ) (“The Company”, “SFWJ”) subsidiary Medcana has acquired a controlling stake in Eko2o Environmental Solutions S.A.S. of Medellin, Antioquia. a company focused on developing infrastructure for agriculture, primarily with greenhouse construction and irrigation systems in Colombia and South America. With... Read more
Ryan Allway November 3rd, 2022 BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today that as part of the PCT patent application process for the EZ-G device, an International Searching Authority (“ISA”) examiner has provided a preliminary, non-binding opinion that one of the... Read more
Christina Lake Cannabis Reports Third Quarter Fiscal 2022 Results
November 2, 2022
Ryan Allway November 2nd, 2022 News, Top News Total sales grew 25% quarter over quarter, and 126% from Q3’21 Total revenue increased to $2.9M from $2.3M in Q2’22, and $1.3M in Q3’21 Gross margin before fair value adjustments of 48% General and administrative expenses decreased to 35% of revenue... Read more
harmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA
November 2, 2022
VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) — PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug Administration (USFDA) in advance of its pre-IND meeting scheduled for later this month. PharmAla will be requesting FDA... Read more
Protext Mobility, Inc. (Txtm) and Rsammda LLC (Delaware) Provides Shareholder Update
November 1, 2022
Wilmington, Delaware | November 01, 2022 02:57 PM Eastern Daylight Time Protext Mobility, Inc. (OTC PINK: TXTM) and RSAMMDA LLC (Delaware) (“RSAMMDA.LLC”) are pleased to provide the following shareholder update and announce an initial order for 2.33 million pounds of Genus Cannabis Sativa under a supply agreement. Dr. Ahmed Jamaloodeen (Dr.J),... Read more
Ryan Allway November 1st, 2022 News, Top News BOCA RATON, FL / ACCESSWIRE / November 1, 2022 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, is pleased to announce that it has closed... Read more
Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors
November 1, 2022
Ryan Allway November 1st, 2022 News, Top News AUSTIN, Texas, November 01, 2022–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), today announced the appointment of Dr. Nat Calloway to... Read more
